These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 6995308)

  • 61. Characterization of a cationic surfactant-resistant mutant isolated spontaneously from Escherichia coli.
    Ishikawa S; Matsumura Y; Yoshizako F; Tsuchido T
    J Appl Microbiol; 2002; 92(2):261-8. PubMed ID: 11849354
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Bacteriophage-resistant mutants of Escherichia coli K12 with altered lipopolysaccharide. Studies with concanavalin A.
    Picken RN; Beacham IR
    J Gen Microbiol; 1977 Oct; 102(2):319-26. PubMed ID: 336846
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Functional organization of the outer membrane of escherichia coli: phage and colicin receptors as components of iron uptake systems.
    Braun V; Hancock RE; Hantke K; Hartmann A
    J Supramol Struct; 1976; 5(1):37-58. PubMed ID: 136550
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Separation of sublethal and lethal effects of the bactericidal/permeability increasing protein on Escherichia coli.
    Mannion BA; Weiss J; Elsbach P
    J Clin Invest; 1990 Mar; 85(3):853-60. PubMed ID: 2179269
    [TBL] [Abstract][Full Text] [Related]  

  • 65. meoA is the structural gene for outer membrane protein c of Escherichia coli K12.
    van Alphen L; Lugtenberg B; van Boxtel R; Hack AM; Verhoef C; Havekes L
    Mol Gen Genet; 1979 Jan; 169(2):147-55. PubMed ID: 375004
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Characterization of a series of transconjugant mutants of an avian pathogenic Escherichia coli isolate for resistance to serum complement.
    Lynne AM; Skyberg JA; Logue CM; Doetkott C; Foley SL; Nolan LK
    Avian Dis; 2007 Sep; 51(3):771-6. PubMed ID: 17992940
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Cell surface properties of organic solvent-tolerant mutants of Escherichia coli K-12.
    Aono R; Kobayashi H
    Appl Environ Microbiol; 1997 Sep; 63(9):3637-42. PubMed ID: 9293016
    [TBL] [Abstract][Full Text] [Related]  

  • 68. The interaction of Escherichia coli with normal human serum: factors affecting the capacity of serum to mediate lipopolysaccharide release.
    Tesh VL; Morrison DC
    Microb Pathog; 1988 Mar; 4(3):175-87. PubMed ID: 3143040
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Mediation of serum resistance in Salmonella typhimurium by an 11-kilodalton polypeptide encoded by the cryptic plasmid.
    Hackett J; Wyk P; Reeves P; Mathan V
    J Infect Dis; 1987 Mar; 155(3):540-9. PubMed ID: 3543157
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Glycine, serine and threonine metabolism confounds efficacy of complement-mediated killing.
    Cheng ZX; Guo C; Chen ZG; Yang TC; Zhang JY; Wang J; Zhu JX; Li D; Zhang TT; Li H; Peng B; Peng XX
    Nat Commun; 2019 Jul; 10(1):3325. PubMed ID: 31346171
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Variation in the susceptibility of bovine mycoplasmas to killing by the alternative complement pathway in bovine serum.
    Howard CJ
    Immunology; 1980 Nov; 41(3):561-8. PubMed ID: 7007210
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Role of lipopolysaccharide in assembly of Escherichia coli outer membrane proteins OmpA, OmpC, and OmpF.
    Ried G; Hindennach I; Henning U
    J Bacteriol; 1990 Oct; 172(10):6048-53. PubMed ID: 2170338
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Mutations in the waaR gene of Escherichia coli which disrupt lipopolysaccharide outer core biosynthesis affect cell surface retention of group 2 capsular polysaccharides.
    Taylor CM; Goldrick M; Lord L; Roberts IS
    J Bacteriol; 2006 Feb; 188(3):1165-8. PubMed ID: 16428421
    [TBL] [Abstract][Full Text] [Related]  

  • 74. The relative importance of the classical and alternative complement pathways in serum bactericidal activity against Escherichia coli.
    Roberts AP; Phillips R
    J Med Microbiol; 1983 Feb; 16(1):69-74. PubMed ID: 6401815
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Comparison of the effects of different lipopolysaccharides on the serum bactericidal reactions of two strains of Escherichia coli.
    Allen RJ; Scott GK
    Infect Immun; 1981 Feb; 31(2):831-2. PubMed ID: 7012024
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Surface expression of O-specific lipopolysaccharide in Escherichia coli requires the function of the TolA protein.
    Gaspar JA; Thomas JA; Marolda CL; Valvano MA
    Mol Microbiol; 2000 Oct; 38(2):262-75. PubMed ID: 11069653
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Mutational change of membrane architecture. Mutants of Escherichia coli K12 missing major proteins of the outer cell envelope membrane.
    Schweizer M; Schwarz H; Sonntag I; Henning U
    Biochim Biophys Acta; 1976 Oct; 448(3):474-91. PubMed ID: 788790
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Effects of lipopolysaccharide structure on lycopene production in Escherichia coli.
    Cui M; Wang Z; Hu X; Wang X
    Enzyme Microb Technol; 2019 May; 124():9-16. PubMed ID: 30797484
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Participation of immunoglobulins and complement components in the intracellular killing of Staphylococcus aureus and Escherichia coli by human granulocytes.
    Leijh PC; van den Barselaar MT; Daha MR; van Furth R
    Infect Immun; 1981 Sep; 33(3):714-24. PubMed ID: 7026443
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Penetration of moxalactam into its target proteins in Escherichia coli K-12: comparison of a highly moxalactam resistant mutant with its parent strain.
    Komatsu Y; Murakami K; Nishikawa T
    Antimicrob Agents Chemother; 1981 Nov; 20(5):613-9. PubMed ID: 6459762
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.